Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (101-110 of 1,023) with videos related to

Pageof 103
Sort By:
Cardiology Clinics|October 22, 2008
Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?Hemanth Neeli, Daniel J Rader
JAMA Cardiology|October 29, 2025
Should Familial Hypercholesterolemia Be Included in Newborn Screening?Daniel J Rader, Sarah Schmidt
Current Atherosclerosis Reports|April 28, 2012
Sortilin as a regulator of lipoprotein metabolismAlanna Strong, Daniel J Rader
Molecular Biosystems|November 10, 2010
Correlating allostery with rigidityA J Rader, Stephen M Brown
Clinical Chemistry|November 17, 2010
Phospholipidation of HDL--how much is too much?William R Lagor, Daniel J Rader
Rheumatic Diseases Clinics of North America|September 1, 1999
Management of lipid disordersC A Friedrich, D J Rader
Current Atherosclerosis Reports|December 21, 2000
Gene therapy for dyslipidemia: clinical prospectsD J Rader, U J Tietge
Cleveland Clinic Journal of Medicine|August 27, 2005
Demystifying triglycerides: a practical approach for the clinicianRichard L Dunbar, Daniel J Rader
Lancet (London, England)|August 19, 2014
HDL and cardiovascular diseaseDaniel J Rader, G Kees Hovingh
Progress in Lipid Research|January 11, 1991
HDL: structure, function and metabolismH B Brewer, D J Rader
Pageof 103

Showing results (101-110 of 1,023) with videos related to

Sort By:
Pageof 103
Cardiology Clinics|October 22, 2008
Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?Hemanth Neeli, Daniel J Rader
JAMA Cardiology|October 29, 2025
Should Familial Hypercholesterolemia Be Included in Newborn Screening?Daniel J Rader, Sarah Schmidt
Current Atherosclerosis Reports|April 28, 2012
Sortilin as a regulator of lipoprotein metabolismAlanna Strong, Daniel J Rader
Molecular Biosystems|November 10, 2010
Correlating allostery with rigidityA J Rader, Stephen M Brown
Clinical Chemistry|November 17, 2010
Phospholipidation of HDL--how much is too much?William R Lagor, Daniel J Rader
Rheumatic Diseases Clinics of North America|September 1, 1999
Management of lipid disordersC A Friedrich, D J Rader
Current Atherosclerosis Reports|December 21, 2000
Gene therapy for dyslipidemia: clinical prospectsD J Rader, U J Tietge
Cleveland Clinic Journal of Medicine|August 27, 2005
Demystifying triglycerides: a practical approach for the clinicianRichard L Dunbar, Daniel J Rader
Lancet (London, England)|August 19, 2014
HDL and cardiovascular diseaseDaniel J Rader, G Kees Hovingh
Progress in Lipid Research|January 11, 1991
HDL: structure, function and metabolismH B Brewer, D J Rader
Pageof 103